Physicians' Academy for Cardiovascular Education

Targeting TG-rich remnant lipoproteins: Review of new insights and clinical opportunities

This program provide an update of novel findings in basic and clinical science with regard to the association of triglyceride-rich remnant lipoproteins and CV risk. In addition, guidance will be given how to apply these findings in the treatment of patients in clinical practice.

E-learning Targeting TG-rich lipoproteins and their remnants

Accredited e-Learning

Online-CME - This course consists of 3 parts.
This course consists of 3 parts.

What are drivers of lipid-associated residual CV risk when LDL-c levels are at or below target goals? This course provides an update of novel findings in basic and clinical science with regard to the association of triglyceride-rich lipoproteins and their remnants with CV risk. Enroll today! NEW: content of the course also available as text

Slides: Targeting triglyceride-rich remnant lipoproteins

Slides (presentation) - Dec. 21, 2021 - Online series on TG-rich lipoproteins
This lecture by prof. Daniel Gaudet, MD, PhD is part of the online symposium

Slides as educational service to PACE members.

Targeting triglyceride-rich remnant lipoproteins

10' education - Dec. 21, 2021 - Prof. Daniel Gaudet, MD, PhD
Prof. Daniel Gaudet gives an overview of emerging therapies targeting triglyceride-rich remnant lipoproteins.

Prof. Daniel Gaudet gives an overview of emerging therapies targeting triglyceride-rich remnant lipoproteins. With question to test your knowledge.

Why focus on triglyceride-rich lipoproteins and their remnants?

10' education - Nov. 23, 2021 - Prof. Henry Ginsberg, MD
What are triglyceride-rich lipoprotein (TGRL) remnants? How do TGRL remnants differ from LDL and do these differences make them more atherogenic? Prof. Henry Ginsberg answers these questions in this video.

What are triglyceride-rich lipoprotein (TGRL) remnants? How do TGRL remnants differ from LDL and do these differences make them more atherogenic? Prof. Henry Ginsberg answers these questions in this video.

Slides: Why focus on triglyceride-rich lipoproteins?

Slides (presentation) - Nov. 23, 2021 - Online series on TG-rich lipoproteins
This lecture by prof. Henry Ginsberg, MD is part of the online symposium

Slides as educational service to PACE members.

Slides: Triglyceride-rich lipoproteins and residual CV risk

Slides (presentation) - Nov. 23, 2021 - Online series on TG-rich lipoproteins
This lecture by prof. Stroes, MD, PhD is part of the online symposium

Slides as educational service to PACE members.

Triglyceride-rich lipoproteins and residual CV risk

Subtitling in English, German, Italian, Spanish, Chinese and French

10' education - Oct. 14, 2021 - Prof. Erik Stroes, MD, PhD
Is it relevant to discuss hypertriglyceridemia when LDL-c and inflammation are well-controlled? Prof. Stroes discusses the association of triglycerides and triglycerde-rich lipoproteins with CV risk.

Is it relevant to discuss hypertriglyceridemia when LDL-c and inflammation are well-controlled? Prof. Stroes discusses the association of triglycerides and triglycerde-rich lipoproteins with CV risk.

Targeting TG-rich remnant lipoproteins: Review of new insights and clinical opportunities